DAYTONA BEACH, FL--( NewMediaWire ) - Quture International, Inc.
(OTC PINK: QUTR), the proven and experienced
clinical performance and outcome analytics and solutions company in
American healthcare, now with global capability, today announced
the significance of being recognized as one of among the top 50
healthcare solution providers of 2016 by CIO Review. For
further information on this distinction, see Quture's Facebook post
at: https://www.facebook.com/QutureInt/.
Quture's Health Data Science Technology crosses the boundaries
of all customer segments on the QualOptima Informatics Platform and
even within the provider segment to unify health and healthcare
analytics in the market of at least $24 billion in 2016, estimated
to increase to $55 billion by 2021. Quture's steady progression in
2016 included transformation of QualOptima's medical errors
prevention incorporating the Human Factors Analysis &
Classification System (HFACS). The exponential improvement in
QualOptima's Causation Analysis, Classification and
Interventions System will transform quality and risk
management (including adverse event investigation and medical error
interventions).
These dramatic advances and completion of the personalized and
precision health technologies and intellectual property of Quture
are recognized by CIO Review. Quture was notified that
based on an analysis of over 800 companies providing solutions for
the healthcare industry by CIO Review's editorial research
team, Quture was selected based on merit to be part of this annual
Healthcare Technology edition. "It's a great honor to select Quture
as one of the 50 Most Promising Healthcare Solution Providers
2016," said Jeevan George, Managing Editor of CIO Review.
"Quture's QualOptima Connectivity & Analytics System empowers
data-driven decisions to improve health and healthcare while
reducing costs."
Quture has carved its niche through vast experience in reviewing
the clinical performance and outcomes of hundreds of healthcare
organizations, by thousands of physicians, for hundreds of
thousands of patients. Its QualOptima informatics platform
embeds the technology Quture invented and engineered to empower
providers, payers and patients ("P3") for data-driven decisions
("D3") to achieve optimal wellness and health care. Quture's
P3D3© PaaS informatics platform is the complete solution to
transform the fundamental payment, delivery (medical), quality,
analytics, health and scientific models that are the basis of
health care. By anticipating value-driven outcomes for
payment, Quture has become the most promising informatics system
for value-based, optimal clinical, operational and financial
outcomes.
"Our long-term product development strategies have come to
fruition and now recognition as a top 50 healthcare solution
provider," said Landon Feazell, Quture's Chairman &
CEO. "We continue to believe, now more than ever, that our
QualOptima informatics platform is the free-enterprise solution to
the health and health care crises in America. We will be
marketing and selling into another 2-3 years of uncertainty,
perhaps chaos, emerging from what has been eight-plus years of
wrangling over insurance coverage, access to health care, cost and
quality at the federal and state levels. Quture is strategically
positioned in each customer segment for the essential financial and
market drivers across this spectrum of urgent needs."
The Company's strategies focusing on people for wellness and as
patients for disease interception or management will become clear
in 2017. Quture's P3D3© PaaS informatics platform is the complete
solution to the challenges facing health and health care, both
nationally and globally. Quture's technology and informatics
systems provide solutions cross the boundaries of traditional
customer segments, our P3, who will find themselves more isolated
in the healthcare ecosystem uncertainty and urgently needing our D3
complete solution.
Quture's health care provider and insurer customers will come
from those committed to urgent solutions that will determine their
future to thrive from value-driven outcomes. Our pharma,
medical device and mobile apps, as well as omics customers will be
committed to digital and precision health. People, whether
patients or seeking optimal health and wellness, will seek to be
empowered in those endeavors. Quture further intends and has
undertaken new expertise to file our financial information.
Feazell concluded: "I believe that positioning our Company and
product forecast a most favorable 2017 for Quture. We intend
to complete negotiations begun last year that will confirm this
forecast in our most immediate areas of focus. And we also
look forward to reporting our financials with expertise retained
and working with us. With our health, quality of life and, in
fact the American economy at stake, Quture has demonstrated the
same commitments as our customers as we now look forward to
2017."
About CIO Review:
Published from Fremont, California, CIO Review is a print magazine
that explores and understands the plethora of ways adopted by firms
to execute the smooth functioning of their businesses. A
distinguished panel comprising of CEOs, CIOs, IT VPs including CIO
Review editorial board finalized the "50 Most Promising Healthcare
Solution Providers 2016" and shortlisted the best vendors and
consultants. For more info, visit: www.cioreview.com.
About Quture International, Inc.
Quture International (OTC PINK: QUTR) is the proven and experienced
clinical performance and outcome analytics and solutions company in
American healthcare. Quture's first-to-market clinical intelligence
software is the complete solution for healthcare providers, payers,
employers, and insurance companies seeking to achieve optimal
clinical, financial and operational outcomes. Q's QualOptima
Connectivity & Analytics System empowers value-driven,
patient-centered, personalized care focused on real-time and
predictive patient management and patient safety, with optimal
quality demonstrated by outcomes correlated with resource use,
revenue and cost. As an Application Partner of InterSystems
Corporation, Quture's software operates on their HealthShare
strategic technology platform to capture, integrate, aggregate, and
analyze data transformed to knowledge in its innovative
second-generation database. Quture's core competence and value
proposition lies in its embedded evidence-based metrics, clinical
content and analytic algorithms developed from over 35 years of
measuring performance in hundreds of hospitals, physician
organizations and HMO's.
As the free enterprise solution to improving health and
healthcare while reducing costs, Quture is positioned through its
disruptive technology to become the foremost global provider of
value-based clinical intelligence and knowledge solutions. Q is a
Nevada corporation based in Daytona Beach, Florida, and trades on
the OTC exchange under the symbol "QUTR."
Forward Looking Statements: This release
contains forward-looking statements, including, without limitation,
statements concerning our business and possible or assumed future
results of operations. Our actual results could differ materially
from those anticipated in the forward-looking statements for many
reasons including: our ability to continue as a going concern,
adverse economic changes affecting markets we serve; competition in
our markets and industry segments; our timing and the profitability
of entering new markets; greater than expected costs, customer
acceptance of our products or difficulties related to our
integration of the businesses we may acquire; and other risks and
uncertainties as may be detailed from time to time in our public
announcements and SEC filings. Although we believe the expectations
reflected in the forward-looking statements are reasonable, they
relate only to events as of the date on which the statements are
made, and our future results, levels of activity, performance or
achievements may not meet these expectations. We do not intend to
update any of the forward-looking statements after the date of this
document to conform these statements to actual results or to
changes in our expectations, except as required by law. There is no
assurance that a definitive agreement will be completed.